Indications for Lamictal
The U.S. Food and Drug Administration (FDA) has approved lamotrigine as adjunctive therapy for both adults and children aged 2 years and older for
- simple and complex partial seizures
- generalized seizures of Lennox-Gastaut syndrome (LGS)
- primary generalized tonic-clonic seizures
It is also FDA-approved as monotherapy in adults for the treatment of simple and complex partial seizures after conversion from valproate or a single enzyme-inducing antiepileptic drug (carbamazepine, phenytoin, primidone, or phenobarbital).
Last updated: 09/26/2006
